Nitric oxide and cancer therapy: the emperor has NO clothes
JR Hickok, DD Thomas - Current pharmaceutical design, 2010 - ingentaconnect.com
The role of nitric oxide (NO•) as a mediator of cancer phenotype has led researchers to
investigate strategies for manipulating in vivo production and exogenous delivery of this …
investigate strategies for manipulating in vivo production and exogenous delivery of this …
Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities
Nitric oxide (NO) is a pleiotropic molecule critical to a number of physiological and
pathological processes. The last decade has witnessed major advances in dissecting NO …
pathological processes. The last decade has witnessed major advances in dissecting NO …
The regulation of nitric oxide in tumor progression and therapy
Y Hu, J Xiang, L Su, X Tang - Journal of International …, 2020 - journals.sagepub.com
Nitric oxide (NO) is a ubiquitous gas with free radical groups that is soluble in water, and
which is involved in numerous physiological functions including inflammatory and immune …
which is involved in numerous physiological functions including inflammatory and immune …
Nitric oxide—a novel therapeutic for cancer
Much research over the past two decades has focussed on understanding the complex
interactions of nitric oxide (NO) in both physiological and pathological processes. As with …
interactions of nitric oxide (NO) in both physiological and pathological processes. As with …
Targeting nitric oxide for cancer therapy
D Hirst, T Robson - Journal of Pharmacy and Pharmacology, 2007 - Wiley Online Library
A blueprint for the ideal anticancer molecule would include most of the properties of nitric
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …
oxide (NO•), but the ability to exploit these characteristics in a therapeutic setting requires a …
Nitric oxide: cancer target or anticancer agent?
S Mocellin - Current cancer drug targets, 2009 - ingentaconnect.com
Despite the improved understanding of nitric oxide (NO) biology and the large amount of
preclinical experiments testing its role in cancer development and progression, it is still …
preclinical experiments testing its role in cancer development and progression, it is still …
Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies
S Singh, AK Gupta - Cancer chemotherapy and pharmacology, 2011 - Springer
Purpose The diatomic radical nitric oxide (NO) has been the cause of intense debate with
implication in carcinogenesis, tumour progression, invasion, angiogenesis and modulation …
implication in carcinogenesis, tumour progression, invasion, angiogenesis and modulation …
Nitric oxide and cancer: When to give and when to take away?
KM Miranda, LA Ridnour, CL McGinity… - Inorganic …, 2021 - ACS Publications
The mechanistic roles of nitric oxide (NO) during cancer progression have been important
considerations since its discovery as an endogenously generated free radical. Nonetheless …
considerations since its discovery as an endogenously generated free radical. Nonetheless …
Nitric oxide: the forgotten child of tumor metabolism
Nitric oxide (NO) is a signaling molecule with pleiotropic physiological roles in normal cells
and pathophysiological roles in cancer. NO synthetase expression and NO synthesis are …
and pathophysiological roles in cancer. NO synthetase expression and NO synthesis are …
Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy
D Hirst, T Robson - Current pharmaceutical design, 2010 - ingentaconnect.com
Nitric oxide is a key second messenger in most tissues, where it is generated at low
concentrations, predominantly by the catalytic action of two constitutively expressed isoforms …
concentrations, predominantly by the catalytic action of two constitutively expressed isoforms …